Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lipidomic Profiling of Adipose Tissue Reveals an Inflammatory Signature in Cancer-Related and Primary Lymphedema.

Identifieur interne : 000837 ( PubMed/Checkpoint ); précédent : 000836; suivant : 000838

Lipidomic Profiling of Adipose Tissue Reveals an Inflammatory Signature in Cancer-Related and Primary Lymphedema.

Auteurs : Lisa M. Sedger [Australie] ; Dedreia L. Tull [Australie] ; Malcolm J. Mcconville [Australie] ; David P. De Souza [Australie] ; Thusitha W T. Rupasinghe [Australie] ; Spencer J. Williams [Australie] ; Saravanan Dayalan [Australie] ; Daniel Lanzer [Australie] ; Helen Mackie [Australie] ; Thomas C. Lam [Australie] ; John Boyages [Australie]

Source :

RBID : pubmed:27182733

Descripteurs français

English descriptors

Abstract

Cancer-related and primary lymphedema (LE) are associated with the production of adipose tissue (AT). Nothing is known, however, about the lipid-based molecules that comprise LE AT. We therefore analyzed lipid molecules in lipoaspirates and serum obtained from LE patients, and compared them to lipoaspirates from cosmetic surgery patients and healthy control cohort serum. LE patient serum analysis demonstrated that triglycerides, HDL- and LDL-cholesterol and lipid transport molecules remained within the normal range, with no alterations in individual fatty acids. The lipidomic analysis also identified 275 lipid-based molecules, including triacylglycerides, diacylglycerides, fatty acids and phospholipids in AT oil and fat. Although the majority of lipid molecules were present in a similar abundance in LE and non-LE samples, there were several small changes: increased C20:5-containing triacylglycerides, reduced C10:0 caprinic and C24:1 nervonic acids. LE AT oil also contained a signature of increased cyclopropane-type fatty acids and inflammatory mediators arachidonic acid and ceramides. Interestingly C20:5 and C22:6 omega-3-type lipids are increased in LE AT, correlating with LE years. Hence, LE AT has a normal lipid profile containing a signature of inflammation and omega-3-lipids. It remains unclear, however, whether these differences reflect a small-scale global metabolic disturbance or effects within localised inflammatory foci.

DOI: 10.1371/journal.pone.0154650
PubMed: 27182733


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:27182733

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lipidomic Profiling of Adipose Tissue Reveals an Inflammatory Signature in Cancer-Related and Primary Lymphedema.</title>
<author>
<name sortKey="Sedger, Lisa M" sort="Sedger, Lisa M" uniqKey="Sedger L" first="Lisa M" last="Sedger">Lisa M. Sedger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Clinical Medicine, Faculty of Medicine & Health Science, Macquarie University, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Clinical Medicine, Faculty of Medicine & Health Science, Macquarie University, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tull, Dedreia L" sort="Tull, Dedreia L" uniqKey="Tull D" first="Dedreia L" last="Tull">Dedreia L. Tull</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mcconville, Malcolm J" sort="Mcconville, Malcolm J" uniqKey="Mcconville M" first="Malcolm J" last="Mcconville">Malcolm J. Mcconville</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Souza, David P" sort="De Souza, David P" uniqKey="De Souza D" first="David P" last="De Souza">David P. De Souza</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rupasinghe, Thusitha W T" sort="Rupasinghe, Thusitha W T" uniqKey="Rupasinghe T" first="Thusitha W T" last="Rupasinghe">Thusitha W T. Rupasinghe</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Williams, Spencer J" sort="Williams, Spencer J" uniqKey="Williams S" first="Spencer J" last="Williams">Spencer J. Williams</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Dayalan, Saravanan" sort="Dayalan, Saravanan" uniqKey="Dayalan S" first="Saravanan" last="Dayalan">Saravanan Dayalan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lanzer, Daniel" sort="Lanzer, Daniel" uniqKey="Lanzer D" first="Daniel" last="Lanzer">Daniel Lanzer</name>
<affiliation wicri:level="1">
<nlm:affiliation>Daniel Lanzer Clinic, Malvern, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Daniel Lanzer Clinic, Malvern, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mackie, Helen" sort="Mackie, Helen" uniqKey="Mackie H" first="Helen" last="Mackie">Helen Mackie</name>
<affiliation wicri:level="1">
<nlm:affiliation>Macquarie University Hospital, North Ryde, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Macquarie University Hospital, North Ryde, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lam, Thomas C" sort="Lam, Thomas C" uniqKey="Lam T" first="Thomas C" last="Lam">Thomas C. Lam</name>
<affiliation wicri:level="1">
<nlm:affiliation>Macquarie University Hospital, North Ryde, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Macquarie University Hospital, North Ryde, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Boyages, John" sort="Boyages, John" uniqKey="Boyages J" first="John" last="Boyages">John Boyages</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Clinical Medicine, Faculty of Medicine & Health Science, Macquarie University, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Clinical Medicine, Faculty of Medicine & Health Science, Macquarie University, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27182733</idno>
<idno type="pmid">27182733</idno>
<idno type="doi">10.1371/journal.pone.0154650</idno>
<idno type="wicri:Area/PubMed/Corpus">000822</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000822</idno>
<idno type="wicri:Area/PubMed/Curation">000822</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000822</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000822</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000822</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Lipidomic Profiling of Adipose Tissue Reveals an Inflammatory Signature in Cancer-Related and Primary Lymphedema.</title>
<author>
<name sortKey="Sedger, Lisa M" sort="Sedger, Lisa M" uniqKey="Sedger L" first="Lisa M" last="Sedger">Lisa M. Sedger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Clinical Medicine, Faculty of Medicine & Health Science, Macquarie University, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Clinical Medicine, Faculty of Medicine & Health Science, Macquarie University, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tull, Dedreia L" sort="Tull, Dedreia L" uniqKey="Tull D" first="Dedreia L" last="Tull">Dedreia L. Tull</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mcconville, Malcolm J" sort="Mcconville, Malcolm J" uniqKey="Mcconville M" first="Malcolm J" last="Mcconville">Malcolm J. Mcconville</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Souza, David P" sort="De Souza, David P" uniqKey="De Souza D" first="David P" last="De Souza">David P. De Souza</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rupasinghe, Thusitha W T" sort="Rupasinghe, Thusitha W T" uniqKey="Rupasinghe T" first="Thusitha W T" last="Rupasinghe">Thusitha W T. Rupasinghe</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Williams, Spencer J" sort="Williams, Spencer J" uniqKey="Williams S" first="Spencer J" last="Williams">Spencer J. Williams</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Dayalan, Saravanan" sort="Dayalan, Saravanan" uniqKey="Dayalan S" first="Saravanan" last="Dayalan">Saravanan Dayalan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lanzer, Daniel" sort="Lanzer, Daniel" uniqKey="Lanzer D" first="Daniel" last="Lanzer">Daniel Lanzer</name>
<affiliation wicri:level="1">
<nlm:affiliation>Daniel Lanzer Clinic, Malvern, Melbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Daniel Lanzer Clinic, Malvern, Melbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mackie, Helen" sort="Mackie, Helen" uniqKey="Mackie H" first="Helen" last="Mackie">Helen Mackie</name>
<affiliation wicri:level="1">
<nlm:affiliation>Macquarie University Hospital, North Ryde, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Macquarie University Hospital, North Ryde, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lam, Thomas C" sort="Lam, Thomas C" uniqKey="Lam T" first="Thomas C" last="Lam">Thomas C. Lam</name>
<affiliation wicri:level="1">
<nlm:affiliation>Macquarie University Hospital, North Ryde, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Macquarie University Hospital, North Ryde, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Boyages, John" sort="Boyages, John" uniqKey="Boyages J" first="John" last="Boyages">John Boyages</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Clinical Medicine, Faculty of Medicine & Health Science, Macquarie University, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Clinical Medicine, Faculty of Medicine & Health Science, Macquarie University, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adipose Tissue (metabolism)</term>
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Biological Transport</term>
<term>Fatty Acids (metabolism)</term>
<term>Female</term>
<term>Humans</term>
<term>Inflammation Mediators (metabolism)</term>
<term>Lipid Metabolism</term>
<term>Lipids (blood)</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (metabolism)</term>
<term>Male</term>
<term>Metabolomics (methods)</term>
<term>Middle Aged</term>
<term>Neoplasms (complications)</term>
<term>Phospholipids (metabolism)</term>
<term>Severity of Illness Index</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acides gras (métabolisme)</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Indice de gravité médicale</term>
<term>Jeune adulte</term>
<term>Lipides (sang)</term>
<term>Lymphoedème (diagnostic)</term>
<term>Lymphoedème (métabolisme)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mâle</term>
<term>Médiateurs de l'inflammation (métabolisme)</term>
<term>Métabolisme des lipides</term>
<term>Métabolomique ()</term>
<term>Phospholipides (métabolisme)</term>
<term>Sujet âgé</term>
<term>Tissu adipeux (métabolisme)</term>
<term>Transport biologique</term>
<term>Tumeurs ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Lipids</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Fatty Acids</term>
<term>Inflammation Mediators</term>
<term>Phospholipids</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Adipose Tissue</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Metabolomics</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Acides gras</term>
<term>Lymphoedème</term>
<term>Médiateurs de l'inflammation</term>
<term>Phospholipides</term>
<term>Tissu adipeux</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Lipides</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Biological Transport</term>
<term>Female</term>
<term>Humans</term>
<term>Lipid Metabolism</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Severity of Illness Index</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Indice de gravité médicale</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Métabolisme des lipides</term>
<term>Métabolomique</term>
<term>Sujet âgé</term>
<term>Transport biologique</term>
<term>Tumeurs</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Cancer-related and primary lymphedema (LE) are associated with the production of adipose tissue (AT). Nothing is known, however, about the lipid-based molecules that comprise LE AT. We therefore analyzed lipid molecules in lipoaspirates and serum obtained from LE patients, and compared them to lipoaspirates from cosmetic surgery patients and healthy control cohort serum. LE patient serum analysis demonstrated that triglycerides, HDL- and LDL-cholesterol and lipid transport molecules remained within the normal range, with no alterations in individual fatty acids. The lipidomic analysis also identified 275 lipid-based molecules, including triacylglycerides, diacylglycerides, fatty acids and phospholipids in AT oil and fat. Although the majority of lipid molecules were present in a similar abundance in LE and non-LE samples, there were several small changes: increased C20:5-containing triacylglycerides, reduced C10:0 caprinic and C24:1 nervonic acids. LE AT oil also contained a signature of increased cyclopropane-type fatty acids and inflammatory mediators arachidonic acid and ceramides. Interestingly C20:5 and C22:6 omega-3-type lipids are increased in LE AT, correlating with LE years. Hence, LE AT has a normal lipid profile containing a signature of inflammation and omega-3-lipids. It remains unclear, however, whether these differences reflect a small-scale global metabolic disturbance or effects within localised inflammatory foci.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">27182733</PMID>
<DateCreated>
<Year>2016</Year>
<Month>05</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2017</Year>
<Month>07</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>07</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2016</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Lipidomic Profiling of Adipose Tissue Reveals an Inflammatory Signature in Cancer-Related and Primary Lymphedema.</ArticleTitle>
<Pagination>
<MedlinePgn>e0154650</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0154650</ELocationID>
<Abstract>
<AbstractText>Cancer-related and primary lymphedema (LE) are associated with the production of adipose tissue (AT). Nothing is known, however, about the lipid-based molecules that comprise LE AT. We therefore analyzed lipid molecules in lipoaspirates and serum obtained from LE patients, and compared them to lipoaspirates from cosmetic surgery patients and healthy control cohort serum. LE patient serum analysis demonstrated that triglycerides, HDL- and LDL-cholesterol and lipid transport molecules remained within the normal range, with no alterations in individual fatty acids. The lipidomic analysis also identified 275 lipid-based molecules, including triacylglycerides, diacylglycerides, fatty acids and phospholipids in AT oil and fat. Although the majority of lipid molecules were present in a similar abundance in LE and non-LE samples, there were several small changes: increased C20:5-containing triacylglycerides, reduced C10:0 caprinic and C24:1 nervonic acids. LE AT oil also contained a signature of increased cyclopropane-type fatty acids and inflammatory mediators arachidonic acid and ceramides. Interestingly C20:5 and C22:6 omega-3-type lipids are increased in LE AT, correlating with LE years. Hence, LE AT has a normal lipid profile containing a signature of inflammation and omega-3-lipids. It remains unclear, however, whether these differences reflect a small-scale global metabolic disturbance or effects within localised inflammatory foci.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sedger</LastName>
<ForeName>Lisa M</ForeName>
<Initials>LM</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Medicine, Faculty of Medicine & Health Science, Macquarie University, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tull</LastName>
<ForeName>Dedreia L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McConville</LastName>
<ForeName>Malcolm J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Souza</LastName>
<ForeName>David P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rupasinghe</LastName>
<ForeName>Thusitha W T</ForeName>
<Initials>TW</Initials>
<AffiliationInfo>
<Affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Williams</LastName>
<ForeName>Spencer J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>School of Chemistry, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dayalan</LastName>
<ForeName>Saravanan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lanzer</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Daniel Lanzer Clinic, Malvern, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mackie</LastName>
<ForeName>Helen</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Macquarie University Hospital, North Ryde, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lam</LastName>
<ForeName>Thomas C</ForeName>
<Initials>TC</Initials>
<AffiliationInfo>
<Affiliation>Macquarie University Hospital, North Ryde, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boyages</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Medicine, Faculty of Medicine & Health Science, Macquarie University, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Macquarie University Hospital, North Ryde, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>05</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005227">Fatty Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010743">Phospholipids</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Chem. 1972 Jun;18(6):499-502</RefSource>
<PMID Version="1">4337382</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cytokine Growth Factor Rev. 2014 Aug;25(4):453-72</RefSource>
<PMID Version="1">25169849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann N Y Acad Sci. 2008;1131:82-8</RefSource>
<PMID Version="1">18519961</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Org Biomol Chem. 2014 Dec 14;12(46):9427-38</RefSource>
<PMID Version="1">25321346</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2013 May 7;17(5):671-84</RefSource>
<PMID Version="1">23663736</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2013 Jan 4;430(1):225-30</RefSource>
<PMID Version="1">23131562</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cancer Surviv. 2013 Mar;7(1):83-92</RefSource>
<PMID Version="1">23212603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2723-32</RefSource>
<PMID Version="1">21903946</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2014;9(4):e94713</RefSource>
<PMID Version="1">24714646</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2011;17(11):1371-80</RefSource>
<PMID Version="1">22064427</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Psychiatry. 2012 Dec;17(12):1150-2</RefSource>
<PMID Version="1">22182937</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast J. 2010 Jan-Feb;16(1):48-54</RefSource>
<PMID Version="1">19889169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:64-70</RefSource>
<PMID Version="1">24251707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2014 Mar;124(3):915-21</RefSource>
<PMID Version="1">24590276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1263-70</RefSource>
<PMID Version="1">26122375</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>QJM. 2005 Dec;98(12):845-56</RefSource>
<PMID Version="1">16258026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2012 Apr;129(4):835-7</RefSource>
<PMID Version="1">22456355</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphology. 2008 Jun;41(2):52-63</RefSource>
<PMID Version="1">18720912</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2000 Dec;79(6):3172-92</RefSource>
<PMID Version="1">11106622</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2015 Oct;136(4 Suppl):133-4</RefSource>
<PMID Version="1">26397659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Oncol. 2013 May;14(6):500-15</RefSource>
<PMID Version="1">23540561</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Liver Dis. 2001;21(1):27-41</RefSource>
<PMID Version="1">11296694</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Iran Med. 2008 May;11(3):318-21</RefSource>
<PMID Version="1">18426324</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(12):e52021</RefSource>
<PMID Version="1">23272198</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Biochem Cell Biol. 2012 Mar;44(3):435-40</RefSource>
<PMID Version="1">22222895</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphology. 2004 Dec;37(4):175-7</RefSource>
<PMID Version="1">15693531</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Gynaecol Oncol. 2013;34(1):23-7</RefSource>
<PMID Version="1">23589994</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vasc Med. 1997 Nov;2(4):321-6</RefSource>
<PMID Version="1">9575606</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2014 Jun;63(6):2037-50</RefSource>
<PMID Version="1">24458363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2014 May 15;306(10):H1426-34</RefSource>
<PMID Version="1">24633552</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2009 Aug;124(2):438-50</RefSource>
<PMID Version="1">19644258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lipids. 2013 Aug;48(8):839-48</RefSource>
<PMID Version="1">23754307</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2010 Dec;177(6):3202-14</RefSource>
<PMID Version="1">21056998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(2):e56948</RefSource>
<PMID Version="1">23457643</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Reconstr Microsurg. 2016 Jan;32(1):56-65</RefSource>
<PMID Version="1">25893630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 1967 Dec 5;144(3):549-55</RefSource>
<PMID Version="1">6078122</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2009 Sep;175(3):1328-37</RefSource>
<PMID Version="1">19679879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Experientia. 1967 May 15;23(5):355-6</RefSource>
<PMID Version="1">6065766</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Plast Reconstr Aesthet Surg. 2012 Jul;65(7):935-42</RefSource>
<PMID Version="1">22373827</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2012 Apr;129(4):825-34</RefSource>
<PMID Version="1">22456354</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Membr Biol. 2007 May-Jun;24(3):233-42</RefSource>
<PMID Version="1">17520480</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hypertension. 1997 Apr;29(4):1058-63</RefSource>
<PMID Version="1">9095099</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Dermatol Sci. 2014 Mar;73(3):232-40</RefSource>
<PMID Version="1">24284257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2014 Mar;124(3):929-35</RefSource>
<PMID Version="1">24590278</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Phys Chem B. 2014 Dec 4;118(48):13838-48</RefSource>
<PMID Version="1">25380125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2015 Oct;136(4 Suppl):134-5</RefSource>
<PMID Version="1">26397660</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pers Med. 2015 Sep 03;5(3):326-40</RefSource>
<PMID Version="1">26404383</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2006;4(4):199-210</RefSource>
<PMID Version="1">17394403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Nutr. 2015 Sep;145(9):2012-8</RefSource>
<PMID Version="1">26180244</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2015 Jun;135(6):1715-9</RefSource>
<PMID Version="1">25724063</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Med. 2015 Dec 31;5(1):null</RefSource>
<PMID Version="1">26729182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Biol Med (Maywood). 2011 Sep;236(9):997-1004</RefSource>
<PMID Version="1">21844119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Indian J Surg. 2010 Aug;72(4):305-7</RefSource>
<PMID Version="1">22282316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pain Symptom Manage. 2012 Feb;43(2):244-52</RefSource>
<PMID Version="1">21802897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Clin Nutr. 2008 Oct;88(4):941-9</RefSource>
<PMID Version="1">18842780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Beilstein J Org Chem. 2013 Sep 04;9:1807-12</RefSource>
<PMID Version="1">24062846</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prostaglandins Leukot Essent Fatty Acids. 2014 Nov;91(5):227-32</RefSource>
<PMID Version="1">25172358</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Obes Rev. 2016 Apr;17(4):297-312</RefSource>
<PMID Version="1">26712364</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Chem. 2012 Dec 18;84(24):10768-76</RefSource>
<PMID Version="1">23150939</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2012 Apr;129(4):838-47</RefSource>
<PMID Version="1">22456356</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2015 Apr;62(4):905-12</RefSource>
<PMID Version="1">25450212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Lipid Res. 2015 Feb;56(2):277-85</RefSource>
<PMID Version="1">25520429</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lipids. 1995 Jan;30(1):1-14</RefSource>
<PMID Version="1">7760683</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetol Metab Syndr. 2013 May 14;5(1):24</RefSource>
<PMID Version="1">23672807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Obesity (Silver Spring). 2010 May;18(5):937-44</RefSource>
<PMID Version="1">19798063</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microbiol Mol Biol Rev. 1997 Dec;61(4):429-41</RefSource>
<PMID Version="1">9409147</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Hosp Med (Lond). 2015 Sep 2;76(9):542-3</RefSource>
<PMID Version="1">26352716</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1065-77</RefSource>
<PMID Version="1">25724493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lipids Health Dis. 2015;14:65</RefSource>
<PMID Version="1">26123789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nutrients. 2016 Jan;8(1). pii: E23. doi: 10.3390/nu8010023</RefSource>
<PMID Version="1">26742061</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2015 Feb;15(2):104-16</RefSource>
<PMID Version="1">25614320</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ital J Biochem. 2004 Jul;53(2):98-111</RefSource>
<PMID Version="1">15646015</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2012 Feb 1;302(3):H643-53</RefSource>
<PMID Version="1">22159997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2013 Mar;11(1):14-9</RefSource>
<PMID Version="1">23531180</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2007 Aug;56(8):1960-8</RefSource>
<PMID Version="1">17620421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol. 1967 Jul;213(1):235-8</RefSource>
<PMID Version="1">6027923</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Leukoc Biol. 1994 Nov;56(5):533-41</RefSource>
<PMID Version="1">7964160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Glycoconj J. 2014 Apr;31(3):209-19</RefSource>
<PMID Version="1">24310545</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001692" MajorTopicYN="N">Biological Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D050356" MajorTopicYN="Y">Lipid Metabolism</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010743" MajorTopicYN="N">Phospholipids</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4868287</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>02</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>04</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>5</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>5</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>7</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27182733</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0154650</ArticleId>
<ArticleId IdType="pii">PONE-D-16-08417</ArticleId>
<ArticleId IdType="pmc">PMC4868287</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Sedger, Lisa M" sort="Sedger, Lisa M" uniqKey="Sedger L" first="Lisa M" last="Sedger">Lisa M. Sedger</name>
</noRegion>
<name sortKey="Boyages, John" sort="Boyages, John" uniqKey="Boyages J" first="John" last="Boyages">John Boyages</name>
<name sortKey="Dayalan, Saravanan" sort="Dayalan, Saravanan" uniqKey="Dayalan S" first="Saravanan" last="Dayalan">Saravanan Dayalan</name>
<name sortKey="De Souza, David P" sort="De Souza, David P" uniqKey="De Souza D" first="David P" last="De Souza">David P. De Souza</name>
<name sortKey="Lam, Thomas C" sort="Lam, Thomas C" uniqKey="Lam T" first="Thomas C" last="Lam">Thomas C. Lam</name>
<name sortKey="Lanzer, Daniel" sort="Lanzer, Daniel" uniqKey="Lanzer D" first="Daniel" last="Lanzer">Daniel Lanzer</name>
<name sortKey="Mackie, Helen" sort="Mackie, Helen" uniqKey="Mackie H" first="Helen" last="Mackie">Helen Mackie</name>
<name sortKey="Mcconville, Malcolm J" sort="Mcconville, Malcolm J" uniqKey="Mcconville M" first="Malcolm J" last="Mcconville">Malcolm J. Mcconville</name>
<name sortKey="Rupasinghe, Thusitha W T" sort="Rupasinghe, Thusitha W T" uniqKey="Rupasinghe T" first="Thusitha W T" last="Rupasinghe">Thusitha W T. Rupasinghe</name>
<name sortKey="Tull, Dedreia L" sort="Tull, Dedreia L" uniqKey="Tull D" first="Dedreia L" last="Tull">Dedreia L. Tull</name>
<name sortKey="Williams, Spencer J" sort="Williams, Spencer J" uniqKey="Williams S" first="Spencer J" last="Williams">Spencer J. Williams</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000837 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000837 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:27182733
   |texte=   Lipidomic Profiling of Adipose Tissue Reveals an Inflammatory Signature in Cancer-Related and Primary Lymphedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:27182733" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024